![Geoffrey Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Glass
Amministratore Delegato presso
ABZENA PLC
Profilo
Geoffrey Michael Glass was the founder of ClearSciences LLC, founded in 2015, where the title held was President from 2015 to 2017.
Mr. Glass is the founder of Kiniciti, founded in 2021, holding the title of Chief Executive Officer since 2021.
Mr. Glass currently holds the positions of President, Chief Executive Officer & Director at Sancilio & Co., Inc. since 2018, and Chairman & Chief Executive Officer at Abzena Ltd. since 2022.
Former jobs include Independent Director at Avadel Pharmaceuticals Plc from 2018 to 2026, Director at Sancilio Pharmaceuticals Co., Inc. from 2017 to 2018, Director at Locus Biosciences, Inc. from 2015 to 2017, Senior Vice President-Asia Region at Bausch Health Americas, Inc. from 2007 to 2008, President-Products & Technology Commercialization at Patheon, Inc. from 2013 to 2014, Operating Partner at LongueVue Capital LLC, Executive Vice President-Sales & Marketing at Patheon Pharmaceuticals, Inc. in 2009, and President at Banner Life Sciences LLC from 2009 to 2012.
Education includes undergraduate studies at the University of Arizona.
Posizioni attive di Geoffrey Glass
| Società | Posizione | Inizio |
|---|---|---|
| ABZENA PLC | Amministratore Delegato | 22/07/2025 |
Sancilio & Co., Inc.
 Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides Lipidology an emerging field of clinical and non-clinical pharmaceutical research. | Amministratore Delegato | 01/01/2018 |
Kiniciti
 Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies | Amministratore Delegato | 01/01/2021 |
Precedenti posizioni note di Geoffrey Glass
| Società | Posizione | Fine |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Presidente | 12/02/2026 |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products | Amministratore Delegato | 01/09/2018 |
ClearSciences LLC
 ClearSciences LLC MiscellaneousMiscellaneous Operates as a nonclassifiable establishment | Fondatore | 31/12/2017 |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Develops AI-enabled precision medicine for infectious diseases and immunology | Direttore/Membro del Consiglio | 01/10/2017 |
| PATHEON, INC. | Corporate Officer/Principal | 03/06/2014 |
Formazione di Geoffrey Glass
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LongueVue Capital LLC
 LongueVue Capital LLC Investment ManagersFinance LongueVue Capital invests in middle market companies located in the United States with an EBITDA of more than USD 3 million and revenues of up to USD 15 million. The firm focuses on a broad range of sectors and industries. It participates in growth capital, management buyouts, leveraged buyouts, recapitalization, acquisition transaction with an investment size of USD 10 - 50 million. It also acquires controlling interest. | Finance |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides Lipidology an emerging field of clinical and non-clinical pharmaceutical research. | Commercial Services |
ClearSciences LLC
ClearSciences LLC MiscellaneousMiscellaneous Operates as a nonclassifiable establishment | Miscellaneous |
Patheon Pharmaceuticals, Inc.
 Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products | Commercial Services |
Banner Life Sciences LLC
 Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Develops AI-enabled precision medicine for infectious diseases and immunology | Technology Services |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Kiniciti
Kiniciti Information Technology ServicesTechnology Services Develops resources, expertise and capital technology platform to help partner companies accelerate the advancement and adoption of cell & gene therapies | Technology Services |
